Genetic and Epigenetic Basis of Chronic Wounds
Launched by UNIVERSITY OF PITTSBURGH · Jan 3, 2019
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the reasons why some chronic wounds—those that don’t heal as they should—don’t improve over time. The researchers believe that these wounds have specific genetic features that can be identified by examining tissue that is removed during standard wound care. By comparing the genetic information from the wound tissue with samples taken from the blood, the study aims to uncover clues about why these wounds struggle to heal.
To participate in this study, you need to be at least 18 years old and have a chronic wound that has been present for more than four weeks, which could be a diabetic or non-diabetic ulcer. If you have multiple wounds, the largest one will be the focus of the study. It’s important to know that you should be able to understand the study details and provide consent, and pregnant or breastfeeding individuals are not eligible. If you decide to take part, you'll attend study visits where your wound and health will be monitored, helping researchers learn more about chronic wounds and how to treat them better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Willing to comply with protocol instructions, including all study visits and study activities.
- • Chronic wounds (\> than four weeks since onset)
- • Clinically diagnosed diabetic or non-diabetic ulcer.
- • For patients with multiple wounds, the largest wound will be used for the study.
- Exclusion Criteria:
- • Individuals who are deemed unable to understand the procedures, risks and benefits of the study,(i.e. unable to provide informed consent)
- • Pregnant females (self-declared) or lactating
- • Subjects with marked immunodeficiency (HIV/AIDS or immune-suppressive medications)
- • Prisoners
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Chandan K Sen, PhD
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials